Cargando…
MicroRNA-384 Inhibits the Progression of Papillary Thyroid Cancer by Targeting PRKACB
BACKGROUND: Growing evidence shows that dysregulation of miRNAs plays a significant role in papillary thyroid cancer (PTC) tumorigenesis and development. The abnormal expression of miR-384 has been acknowledged in the proliferation or metastasis of some cancers. However, the function and the underly...
Autores principales: | Wang, Yongxia, Wang, Beixi, Zhou, Hong, Zhang, Xiangnan, Qian, Xinlai, Cui, Jing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6973191/ https://www.ncbi.nlm.nih.gov/pubmed/31998791 http://dx.doi.org/10.1155/2020/4983420 |
Ejemplares similares
-
MicroRNA-384 inhibits the progression of breast cancer by targeting ACVR1
por: Wang, Yongxia, et al.
Publicado: (2018) -
PRKACB is downregulated in non-small cell lung cancer and exogenous PRKACB inhibits proliferation and invasion of LTEP-A2 cells
por: CHEN, YONG, et al.
Publicado: (2013) -
MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression
por: Ye, Ying, et al.
Publicado: (2017) -
MicroRNA-139 targets fibronectin 1 to inhibit papillary thyroid carcinoma progression
por: Ye, Ying, et al.
Publicado: (2022) -
MicroRNA-384 inhibits proliferation migration and invasion of glioma by targeting at CDC42
por: Gu, Gengshi, et al.
Publicado: (2018)